Electrophysiological effects of the anticonvulsant remacemide hydrochloride and its metabolite ARL 12495AA on rat CA1 hippocampal neurons in vitro

Neuropharmacology

Volumn 36, Issue 7, 1997, Pages 951-959

  Norris, S K ^a   King, A E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Anticonvulsant; ARL 12495AA; Epilepsy; Hippocampus; N methyl D aspartate (NMDA) receptor; Remacemide hydrochloride; Sustained repetitive firing

Indexed keywords

1 METHYL 1,2 DIPHENYLETHYLAMINE; ANTICONVULSIVE AGENT; DRUG METABOLITE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REMACEMIDE;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EPILEPSY; FEMALE; HIPPOCAMPUS; NERVE EXCITABILITY; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMIDES; ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; FEMALE; HIPPOCAMPUS; NEURONS; PHENETHYLAMINES; RATS; RATS, WISTAR;

EID: 0030764536     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00069-5     Document Type: Article

References (37)

1. + current. Comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil. Brain Research 548: 41-49.
2. Blanton M. G., Lo Turco J. J. and Kriegstein A. R. (1989) Whole cell recording from neurons in slices of reptilian and mammalian cortex. Journal of Neuroscience Methods 30: 203-210.
3. + channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends in Pharmacological Science 8: 57-65.
4. Cheung H., Kamp D. and Harris E. (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Research 13: 107-112.
5. Cramer C. L., Stagnitto M. L., Knowles M. A. and Palmer G. C. (1994) Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life Science 54: 1271-1275.
6. Foster A. C. and Wong E. H. F. (1987) The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. British Journal of Pharmacology 91: 403-409.
7. Garske G. E., Palmer G. C., Napier J. J., Griffith R. C., Freedman L. R., Harris E. W., Ray R., McCreedy S. A., Blosser S. A., Woodhead J. H., White H. S. and Swinyard E. A. (1991) Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat. Epilepsy Research 9: 161-174.
8. Heyn H., McCarthy D. J., Curry S. H., Eisman M. S. and Anders M. W. (1994) Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant. Drug Metabolism Disposition 22: 443-446.
9. Hille B. (1992) Ionic Channels of Excitable Membranes, Second Edition, pp. 23-58. Sinauer, Sunderland, MA.
10. Huettner J. E. and Bean B. P. (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK 801: selective binding to open channels. Proceedings of the National Academy of Science of the U.S.A. 85: 1307-1311.
11. Laffling A. J., Scherr P., McGivern J. G., Patmore L. and Sheridan R. D. (1995) Electrophysiological actions of phenytoin on N-methyl-D-aspartate receptor-mediated responses in rat hippocampus in vitro. British Journal of Pharmacology 115: 67-72.
12. Lang D. G., Wang C. M. and Cooper B. R. (1993) Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. Journal of Pharmacology and Experimental Therapy 266: 829-835.
13. Lees G. and Leach M. J. (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Research 612: 190-199.
14. Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids and a final common pathway for neurologic disorders. New England Journal of Medicine 330: 613-622.
15. Macdonald R. L. (1989) Antiepileptic drug actions. Epilepsia 30 (S1):S19-S28.
16. McLean M. J. and Macdonald R. L. (1983) Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. Journal of Pharmacology and Experimental Therapy 227: 779-789.
17. McLean M. J. and Macdonald R. L. (1986a) Sodium valproate, but not ethosuximide, produces a use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurones in culture. Journal of Pharmacology and Experimental Therapy 237: 1001-1011.
18. McLean M. J. and Macdonald R. L. (1986b) Carbamazepine and 10,11-epoxycarbamazepine produce a use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. Journal of Pharmacology and Experimental Therapy 238: 727-738.
19. McLean M. J. and Macdonald R. L. (1988) Benzodiazepines, but not beta-carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. Journal of Pharmacology and Experimental Therapy 244: 789-795.
20. McNamara J. O., Russell R. D., Rigsbee L. and Bonhaus D. W. (1988) Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models. Neuropharmacology 27: 563-568.
21. Norris S. K. and King A. E. (1995) The anticonvulsant FPL 12495 limits sustained repetitive firing of rat CA1 hippocampal neurones in vitro. British Journal of Pharmacology 116: 107P.
22. Palmer G. C., Murray R. J., Wilson T. C. M., Eisman M. S., Ray R. K., Griffith R. C., Napier J. J., Fedorchuk M., Stagnitto M. L. and Garske G. E. (1992) Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide. Epilepsy Research 12: 9-20.
23. Palmer G. C., Clark B. and Hutchison J. B. (1993) Antiepileptic and neuroprotective potential of remacemide hydrochloride. Drugs of the Future 18: 1021-1042.
24. Rho J. M., Donevan S. D. and Rogawski M. A. (1994) Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and γ-aminobutyric acidA receptors. Annals in Neurology 35: 229-234.
25. Rogawski M. A. (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends in Pharmacological Science 14: 325-331.
26. Srinivasan J., Richens A. and Davies J. A. (1994) The desglycine metabolite of remacemide (FPL 12495) inhibits the release of glutamate from mouse cortical slices. British Journal of Pharmacology 112: 630P.
27. Stagnitto M. L., Palmer G. C., Ordy J. M., Griffith R. C., Napier J. J., Becker C. N., Gentile R. J., Garske G. E., Frankenheim J. M., Woodhead J. H., White H. S. and Swinyard E. A. (1990) Preclinical profile of remacemide: a novel anticonvulsant effective against maximal electroshock seizures in mice. Epilepsy Research 7: 11-28.
28. Subramaniam S., Donevan S. D. and Rogawski M. A. (1993) Effects of the anticonvulsant remacemide and its des-glycine metabolite on NMDA receptor currents in rat hippocampal neurons. Epilepsia 34 (S6): 117.
29. Subramaniam S., Rho R. M., Penix L., Donevan S. D., Fielding R. P. and Rogawski M. A. (1995) Felbamate block of the N-methyl-D-aspartate receptor. Journal of Pharmacology and Experimental Therapy 273: 878-886.
30. Subramaniam S., Donevan S. D. and Rogawski M. A. (1996) Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite. Journal of Pharmacology and Experimental Therapy 276: 161-168.
31. + channels as targets for neuroprotective drugs. Trends in Pharmacological Science 16: 309-316.
32. Upton N. (1994) Mechanisms of action of new anti-epileptic drugs: rational design and serendipitous findings. Trends in Pharmacological Science 15: 456-463.
33. Wamil A. W. and McLean M. J. (1992) Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture. Journal of Pharmacology and Experimental Therapy 260: 376-383.
34. Wamil A. W. and McLean M. J. (1993) Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons. Journal of Pharmacology and Experimental Therapy 267: 218-227.
35. Wamil A. W., Cheung H., Harris E. W. and McLean M. J. (1996) Remacemide HCl and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture. Epilepsy Research 23: 1-14.
36. White H. S., WoIf H. H., Swinyard E. A., Skeen G. A. and Sofia R. D. (1992) A neuropharmacological evaluation of felbamate as a novel anticonvulsant. Epilepsia 33: 564-572.
37. Willow M., Gonoi T. and Catterall W. A. (1985) Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Molecular Pharmacology 27: 549-558.